Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership

C. Dive, S. N. Shishido, PJ Kuhn

Research output: Contribution to journalArticlepeer-review

Abstract

The Kuhn Laboratory at the University of Southern California and the Dive Laboratory at the Cancer Research UK's Manchester Institute are teaming up to apply new cancer cell detection technology to identify patients who will progress after initial treatment. Researchers will take a simple blood sample to identify early those patients whose cancer has returned, while analyzing circulating tumor cells (CTCs) in great detail, providing new clues on the most effective therapy for the patient's cancer.

Original languageEnglish
Pages (from-to)622-624
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume101
Issue number5
Early online date9 Feb 2017
DOIs
Publication statusPublished - 31 May 2017

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership'. Together they form a unique fingerprint.

Cite this